Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01213706 · ClinicalTrials.gov registry record · NA

Effect of Whole Body Periodic Acceleration on Airway Endothelial Function

A NA study of Healthy and Asthma, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT01213706 is a NA study of Healthy and Asthma that has completed, run by University of Miami. The registered enrollment target is 45 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01213706, a NA study of Healthy and Asthma, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

In the present proposal the investigators wish to assess the effect of a single session with the device known as Exer-Rest® which applies Whole Body Periodic Acceleration (WBPA) on baseline airway blood flow (Qaw) and in Qaw variation, in current smokers, glucocorticoid-naïve asthmatics, and age-matched healthy never-smokers, with the expectation that the treatment will transiently increase the Qaw, and to a greater extent in the current smokers and patients with asthma who have endothelial dysfunction.

Interventions

  • DEVICE Whole Body Periodic Acceleration (WBPA)
  • DEVICE Sham WBPA

Study Locations (1)

Florida

  • Pulmonary Human Research Laboratory, University of Miami Miller School of Medicine - Miami

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2009-10
Est. Completion 2011-05
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT01213706

The ClinicalTrials.gov registry entry for NCT01213706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Whole Body Periodic Acceleration (WBPA) is the first listed.

NCT01213706 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01213706 about?

NCT01213706 is a clinical study titled "Effect of Whole Body Periodic Acceleration on Airway Endothelial Function". In the present proposal the investigators wish to assess the effect of a single session with the device known as Exer-Rest® which applies Whole Body Periodic Acceleration (WBPA) on baseline airway blood flow (Qaw) and in Qaw variation, in current smokers, glucocorticoid-naïve asthmatics, and age-mat...

What is the current status of trial NCT01213706?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2009-10. Estimated completion is 2011-05.

What conditions does trial NCT01213706 study?

This clinical trial studies the following conditions: Healthy, Asthma, Smokers.

What interventions are being tested in trial NCT01213706?

The interventions under investigation include: Whole Body Periodic Acceleration (WBPA) (DEVICE), Sham WBPA (DEVICE).

Who is sponsoring clinical trial NCT01213706?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01213706 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.